FOCUSED ONCOLOGY RESEARCH SERVICES
Oncology statistical analysis and cancer trial-landscape services.
Defined questions. Clear deliverables. Appropriate expertise.
OncoMetrika provides focused statistical analysis, Oncology Evidence Sprints, trial-landscape research and independent design review for emerging biotechnology companies, oncology researchers and specialist consultancies.
SERVICE 01
Oncology Trial Landscape Brief
A focused, source-linked review of public oncology trials for one target, indication or modality. Designed to help emerging biotechnology companies and research teams understand the current development landscape, compare trial approaches and identify important evidence gaps.
Deliverables
Relevant active and recently completed trials · Sponsor, phase, population and treatment-arm mapping · Cohort, endpoint and eligibility comparisons · Important trial updates and design observations · Evidence gaps and questions for further investigation · A concise report and structured Excel table
The final scope depends on the target, indication, number of relevant trials and intended use of the research.
SERVICE 02
Oncology Statistical Analysis Sprint
A defined statistical engagement for an oncology dataset or research question. The work is scoped around a specific analytical objective, dataset and deliverable rather than an open-ended consulting assignment.
Deliverables may include
A documented analysis plan · Descriptive and exploratory analysis · Survival or response analyses where appropriate · Reproducible tables and figures · Statistical code and methods documentation · A concise interpretation of findings and limitations
Methods and deliverables are confirmed after reviewing the research question, data structure and available documentation.
SERVICE 03
Phase I Statistical Design Review
A focused independent review of a draft Phase I oncology protocol or clinical synopsis before important design decisions are finalized.
The review may cover
Dose-escalation structure · Expansion-cohort logic · Endpoints and estimands · Sample-size rationale · Missing-data considerations · Assumptions requiring simulation or sensitivity analysis
When additional senior or specialist expertise is required, proposed contributors are identified and approved by the client before work begins.
SERVICE 04
Oncology Evidence Sprint
A focused engagement that turns one defined cancer research or clinical-development question into a reproducible, review-ready analytical package.
Suggested deliverables
A concise question and analysis specification · Reproducible statistical analysis · Decision-focused tables and figures · Patient-level or cohort-level views where appropriate · A short interpretation note describing findings, limitations and next questions
Suitable use cases
Exploring response timing and durability · Connecting biomarkers with clinical events · Reviewing early safety and exposure patterns · Preparing analysis-ready figures for an internal review, publication or investor discussion · Testing the feasibility of a larger statistical engagement
This is an accessible, tightly scoped starting engagement. It does not replace a full statistical analysis plan, regulatory submission package, CRO or long-term biometrics support.
Need a clear answer from complex oncology evidence?
Tell us the question, dataset or development challenge. We will propose a focused scope and identify any additional expertise required.
Need a clear answer from complex oncology evidence?
Tell us the question, dataset or development challenge. We will propose a focused scope and identify any additional expertise required.
Need a clear answer from complex oncology evidence?
Tell us the question, dataset or development challenge. We will propose a focused scope and identify any additional expertise required.